Mon, Mar 2, 2015, 10:57 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Curis, Inc. Message Board

  • biobrainx biobrainx Apr 11, 2013 8:30 AM Flag

    Q1 sales

    I got this in German and Google translate was not so good
    In den ersten drei Monaten trieben vor allem die umsatzstarken Krebsmedikamente MabThera, Herceptin und Avastin das Wachstum. Daneben liefen die Verkäufe der neuen Krebsmittel Zelboraf, Erivedge und Perjeta gut an.
    In the first three months driven primarily-selling cancer drug MabThera, Herceptin and Avastin growth. Besides running the sales of the new cancer drug Zelboraf, and Erivedge Perjeta good.

3.080.00(0.00%)Mar 2 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.